These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 26453465)
1. Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? Mameli G; Madeddu G; Cossu D; Galleri G; Manetti R; Babudieri S; Mura MS; Sechi LA Eur J Neurol; 2016 Jan; 23(1):140-7. PubMed ID: 26453465 [TBL] [Abstract][Full Text] [Related]
2. Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients. Cossu D; Mameli G; Galleri G; Cocco E; Masala S; Frau J; Marrosu MG; Manetti R; Sechi LA Mult Scler; 2015 Jul; 21(8):984-95. PubMed ID: 25392335 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients. Mameli G; Cossu D; Cocco E; Masala S; Frau J; Marrosu MG; Sechi LA J Neuroimmunol; 2014 May; 270(1-2):51-5. PubMed ID: 24642384 [TBL] [Abstract][Full Text] [Related]
4. Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients. Mameli G; Cocco E; Frau J; Marrosu MG; Sechi LA Sci Rep; 2016 Mar; 6():22401. PubMed ID: 26956729 [TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry. Bo M; Erre GL; Niegowska M; Piras M; Taras L; Longu MG; Passiu G; Sechi LA Clin Exp Rheumatol; 2018; 36(3):376-381. PubMed ID: 29352853 [TBL] [Abstract][Full Text] [Related]
6. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296 [TBL] [Abstract][Full Text] [Related]
16. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis. Mueller NE; Lennette ET; Dupnik K; Birmann BM Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472 [TBL] [Abstract][Full Text] [Related]
17. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124 [TBL] [Abstract][Full Text] [Related]
18. Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1. Steigerwald-Mullen P; Kurilla MG; Braciale TJ J Virol; 2000 Aug; 74(15):6748-59. PubMed ID: 10888613 [TBL] [Abstract][Full Text] [Related]
19. Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients. Arru G; Caggiu E; Leoni S; Mameli G; Pugliatti M; Sechi GP; Sechi LA J Neurol Sci; 2015 Oct; 357(1-2):106-8. PubMed ID: 26190523 [TBL] [Abstract][Full Text] [Related]
20. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. Long HM; Chagoury OL; Leese AM; Ryan GB; James E; Morton LT; Abbott RJ; Sabbah S; Kwok W; Rickinson AB J Exp Med; 2013 May; 210(5):933-49. PubMed ID: 23569328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]